Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Fundacion De Oftalmologia Medica De La Comunitat Valenciana

Spain Avinguda Pio Baroja Escriptor 12, 46015 Valencia, Spain

  • 4 trials recruiting
  • Persistent corneal epithelial defect · Atopic keratoconjunctivitis · Dry age-related macular degeneration
  • Adults and children

About Specializations

Fundacion De Oftalmologia Medica De La Comunitat Valenciana in Valencia, Spain specialises in clinical trials of conditions such as Persistent corneal epithelial defect, Atopic keratoconjunctivitis, Dry age-related macular degeneration, Polypoidal choroidal vasculopathy, and other specialisations. This site conducts important research.

Main research areas of the site

Eye Diseases and Ocular Physiology

At Fundacion De Oftalmologia Medica De La Comunitat Valenciana, much of the research focuses on eye diseases and related ocular physiological phenomena. The trials examine conditions such as dry eye, meibomian gland dysfunction, atopic keratoconjunctivitis, vernal keratoconjunctivitis, persistent corneal epithelial defect, and age-related macular degeneration, with the goal of improving symptom control, healing, and overall eye health.

  • Testing new approaches for dry eye disease and meibomian gland dysfunction
  • Evaluating treatments for allergic eye conditions such as AKC and VKC
  • Studying therapies aimed at supporting corneal repair and vision preservation
  • Assessing options for retinal diseases including AMD and polypoidal choroidal vasculopathy

These studies are designed to measure how well new or existing therapies work, while also monitoring safety and patient comfort in everyday eye care.

Viral and Respiratory Infections

The site also conducts trials in viral diseases and respiratory tract diseases, including research on respiratory syncytial virus and influenza immunisation. This work is centered on strengthening immune protection in older adults and understanding how well vaccines help prevent serious respiratory illness.

  • Evaluating immune responses to RSV vaccination in older adults
  • Assessing the safety and effectiveness of influenza vaccines
  • Supporting prevention strategies for seasonal respiratory infections

These trials aim to improve protection against common but potentially serious infections, especially in populations at higher risk.

Bacterial Infections and Vaccines

Research in bacterial infections at this patient organisation includes studies on pneumococcal disease and vaccine response. The main purpose is to evaluate whether newer vaccines can provide strong immune protection while remaining safe and well tolerated.

  • Studying immune responses to pneumococcal vaccination
  • Comparing vaccine performance in older adults
  • Measuring protection against serious bacterial infection

By focusing on prevention, these trials help clarify how vaccination can reduce the burden of infections in the community.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Avinguda Pio Baroja Escriptor 1246015 ValenciaSpain
Open in maps ↗
Recruiting now
4 trials
Conditions studied
9

More sites in ValenciaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Persistent corneal epithelial defect

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.

Atopic keratoconjunctivitis

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-Hex-4-En-2-Yl]-4,7,10,12,15,19,25,28-Octamethyl-33-(Methylamino)-6,9,18,24-Tetrakis(2-Methylpropyl)-3,21-Di(Propan-2-Yl)-1-Oxa-4,7,10,13,16,19,22,25,28,31-Decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-Undecone Hydrochloride
  • Sponsor:Dompe' Farmaceutici S.p.A.

Dry age-related macular degeneration

Recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:XELAFASLATIDE
  • Sponsor:ONL Therapeutics Inc.

Polypoidal choroidal vasculopathy

Recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:Association For Innovation And Biomedical Research On Light And Image

Conjunctivitis allergic+1

Not yet recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Ciclosporin
  • Sponsor:Laboratoires Thea

Pneumococcal infection

Not recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Abc-15A-116
  • Sponsor:Merck Sharp & Dohme LLC

Dry eye+1

Not recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Hydrocortisone Sodium Phosphate
  • Sponsor:Laboratorios Thea S.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.